Mubadala Investment Company, Abu Dhabi’s state-owned investment fund, is making strides in integrating artificial intelligence into its decision-making processes. The firm has announced plans to ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

It also complements KELIX bio’s recent acquisition of four GlobalOne Healthcare Holding assets. About Mubadala Investment Company Mubadala Investment Company is a sovereign investor managing a global ...

Abu Dhabi’s Mubadala Investment Company has partnered with Blue Opal Capital, a US venture capital firm specializing in investing in other venture capital funds (fund-of-funds). This strategic ...

Mubadala Investment Company has released its 2022 financial results for the Group.Despite a challenging macroeconomic environment in 2022 that significantly impacted financial markets and investor ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu Dhabi sovereign investor Mubadala Investment Company ...

KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...